CN Stock MarketDetailed Quotes

002728 Teyi Pharmaceutical Group

Watchlist
  • 9.38
  • -0.17-1.78%
Market Closed Apr 26 15:00 CST
4.79BMarket Cap30.55P/E (TTM)

Teyi Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Teyi Pharmaceutical Group Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 20, 2024

Revenue(YoY)

164.61M

-45.88%
EPS(YoY)

0.03

-93.18%
Analyst Rating

Strong Buy

Apr 28, 2024

Teyi Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.378B--
--2024/FY-- / 1.165B--
Mar 8, 20242023/FY1.067B / 1.151B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.378B--
--2024/FY-- / 1.165B--
Mar 8, 20242023/FY1.067B / 1.151B--

Teyi Pharmaceutical Group Earnings Reports

  • Teyi Pharmaceutical: Report for the first quarter of 2024

    Apr 20 00:00

  • Teyi Pharmaceutical: 2023 Annual Report Summary

    Mar 8 00:00

  • Teyi Pharmaceutical: 2023 Annual Report

    Mar 8 00:00

  • Teyi Pharmaceutical: 2023 Annual Results Forecast

    Jan 13 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg